https://healthreviewmacao.com/article/907587196-avita-medical-to-announce-first-quarter-2026-financial-results Health Review Macao en PressRelease 2026-04-23T20:10:00+00:00 AVITA Medical to Announce First Quarter 2026 Financial Results https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://healthreviewmacao.com/article/907586585-dyne-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://healthreviewmacao.com/article/907587189-outlook-therapeutics-announces-closing-of-5-0-million-registered-direct-offering Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://healthreviewmacao.com/article/907587246-trevi-therapeutics-to-participate-in-upcoming-may-events Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 Trevi Therapeutics to Participate in Upcoming May Events https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://healthreviewmacao.com/article/907587485-heartflow-to-report-first-quarter-2026-financial-results-on-may-14-2026 Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026 https://ml.globenewswire.com/media/c6be111e-2f8e-4ac8-8fa8-310dbcbd6e15/small/25-1113-cmyk-hf-logo-positive-png.png https://healthreviewmacao.com/article/907587550-leonabio-to-host-virtual-key-opinion-leader-event-highlighting-potential-of-lasofoxifene-in-treatment-resistant-er-her2-esr1-mutated-metastatic Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://healthreviewmacao.com/article/907587597-cytek-biosciences-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/5a33b17c-e545-48d8-b797-832cf8e4372c/small/cytek-logo-color-jpg.jpg https://healthreviewmacao.com/article/907588857-itonic-holdings-ltd-granted-an-extension-of-additional-180-day-by-nasdaq-to-regain-compliance-with-minimum-bid-price-rule Health Review Macao en PressRelease 2026-04-23T20:05:00+00:00 iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule https://ml.globenewswire.com/media/7785d449-a9e0-4ea1-86eb-ff46d45db4db/small/phetonlogo-jpg.jpg https://healthreviewmacao.com/article/907586362-kiniksa-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-april-28-2026 Health Review Macao en PressRelease 2026-04-23T20:01:00+00:00 Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 https://ml-eu.globenewswire.com/media/84055882-69ed-48db-be7d-99cc55be5ff3/small/image1-jpg.jpg https://healthreviewmacao.com/article/907586974-weight-watchers-schedules-first-quarter-2026-earnings-conference-call Health Review Macao en PressRelease 2026-04-23T20:01:00+00:00 Weight Watchers Schedules First Quarter 2026 Earnings Conference Call https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://healthreviewmacao.com/article/907587307-tectonic-therapeutic-appoints-jessica-chutter-to-board-of-directors Health Review Macao en PressRelease 2026-04-23T20:01:00+00:00 Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors https://ml.globenewswire.com/media/7c13d2a1-2971-4ab0-a4b5-608923316546/small/tectonic-logo-full-color-png.png https://healthreviewmacao.com/article/907590339-the-root-brands-earns-national-recognition-for-patent-driven-wellness-innovation-and-science-backed-consumer-products Health Review Macao en PressRelease 2026-04-23T19:53:45+00:00 The ROOT Brands Earns National Recognition for Patent‑Driven Wellness Innovation and Science‑Backed Consumer Products https://ml.globenewswire.com/media/NTRkM2NjZTItMGM5Yy00OWVjLTk0M2MtM2Q1YWI1NzI0NWU4LTUwMDE1MDU0NC0yMDI2LTA0LTIzLWVu/tiny/The-ROOT-Brands.png https://healthreviewmacao.com/article/907589890-regeneron-announces-agreement-with-u-s-government-to-help-lower-drug-costs-for-american-patients-and-will-provide-innovative-new-gene-therapy-for Health Review Macao en PressRelease 2026-04-23T19:46:16+00:00 Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S. https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://healthreviewmacao.com/article/907589070-this-alcohol-awareness-month-oxford-treatment-center-raises-red-flag-citing-significant-rise-in-patients-seeking-help-for-alcohol-addiction Health Review Macao en PressRelease 2026-04-23T19:45:00+00:00 This Alcohol Awareness Month, Oxford Treatment Center Raises Red Flag, Citing Significant Rise in Patients Seeking Help for Alcohol Addiction https://ml.globenewswire.com/media/0b3eec6b-83f7-4bfa-8d29-d07dbb759e65/small/oxford-logo-jpg.jpg https://healthreviewmacao.com/article/907589816-cook-county-health-recognizes-60th-anniversary-of-trauma-unit Health Review Macao en PressRelease 2026-04-23T19:38:53+00:00 Cook County Health Recognizes 60th Anniversary of Trauma Unit https://ml.globenewswire.com/media/NDQ1YjhiYjctOTZhNS00YjAxLWI1ZGQtNjkzN2EzNzY5MmUyLTUwMDEyMzk3My0yMDI2LTA0LTIzLWVu/tiny/Cook-County-Health.png https://healthreviewmacao.com/article/907589540-hormify-launches-transparent-research-based-supplement-for-hormonal-balance-and-daily-wellness Health Review Macao en PressRelease 2026-04-23T19:27:22+00:00 Hormify Launches Transparent, Research-Based Supplement for Hormonal Balance and Daily Wellness https://ml.globenewswire.com/media/e538c302-eeee-4287-9d09-5cc8e08f5b4c/small/555-jpg.jpg https://healthreviewmacao.com/article/907588094-ai-powered-nerve-monitoring-systems-poised-to-transform-surgical-safety-as-workforce-shortages-drive-remote-monitoring-adoption Health Review Macao en PressRelease 2026-04-23T18:03:16+00:00 AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://healthreviewmacao.com/article/907587687-progyny-inc-announces-details-for-its-first-quarter-2026-results-report Health Review Macao en PressRelease 2026-04-23T17:55:46+00:00 Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://healthreviewmacao.com/article/907570099-grace-therapeutics-provides-regulatory-update-on-new-drug-application-for-gtx-104 Health Review Macao en PressRelease 2026-04-23T17:13:24+00:00 Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 https://ml.globenewswire.com/media/c71c0a95-caed-4520-87a9-ac7fefef3f07/small/grce-logo-jpg.jpg https://healthreviewmacao.com/article/907570032-otarmeni-lunsotogene-parvec-cwha-approved-by-fda-as-first-and-only-gene-therapy-for-genetic-hearing-loss-regeneron-to-provide-otarmeni-for-free-in Health Review Macao en PressRelease 2026-04-23T16:40:00+00:00 Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S. https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://healthreviewmacao.com/article/907569967-pridcor-therapeutics-secures-global-antiviral-portfolio-establishing-leadership-in-treatment-of-long-covid-and-infection-associated-chronic-illnesses Health Review Macao en PressRelease 2026-04-23T16:14:40+00:00 PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses https://ml.globenewswire.com/media/c6e61521-f249-47fc-ba7e-29e8c1ed809f/small/untitled-design-png.png https://healthreviewmacao.com/article/907567815-orchestra-biomed-to-present-avim-therapy-clinical-and-mechanistic-data-at-hrs-2026 Health Review Macao en PressRelease 2026-04-23T16:00:00+00:00 Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://healthreviewmacao.com/article/907568034-catheter-precision-to-attend-and-share-new-clinical-data-at-the-47th-annual-heart-rhythm-society-meeting Health Review Macao en PressRelease 2026-04-23T16:00:00+00:00 Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://healthreviewmacao.com/article/907566642-chiffre-d-affaires-du-1er-trimestre-2026 Health Review Macao en PressRelease 2026-04-23T15:45:00+00:00 Chiffre d’affaires du 1er trimestre 2026 https://ml-eu.globenewswire.com/media/c4731c25-21f2-47d1-910e-edbaeb4de604/small/ https://healthreviewmacao.com/article/907566874-q1-2026-revenue Health Review Macao en PressRelease 2026-04-23T15:45:00+00:00 Q1 2026 revenue https://ml-eu.globenewswire.com/media/c4731c25-21f2-47d1-910e-edbaeb4de604/small/logo-color-cmjn-bd-jpg.jpg https://healthreviewmacao.com/article/907549633-fsr-in-partnership-with-ats-welcomes-dr-matt-craig-to-drive-strategic-research-initiatives Health Review Macao en PressRelease 2026-04-23T14:35:37+00:00 FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives https://ml.globenewswire.com/media/cb9862de-da73-457c-922e-18812ff4e604/medium/j-matt-craig-phd-joins-fsr-and-ats.png https://healthreviewmacao.com/article/907546299-new-data-quantifies-the-nasm-premium-certified-professionals-earn-22-more-than-industry-peers Health Review Macao en PressRelease 2026-04-23T14:34:00+00:00 New Data Quantifies the "NASM Premium": Certified Professionals Earn 22% More Than Industry Peers https://ml.globenewswire.com/media/ZDk4NDBjYzYtNmUyOC00ZTQ1LTk2ZjgtNzY0OWVlMWRmM2YxLTEyNjU1NTctMjAyNi0wNC0yMy1lbg==/tiny/The-National-Academy-of-Sports.png https://healthreviewmacao.com/article/907549599-mother-s-day-gift-ideas-for-moms-experiential-gifts-like-cooking-together-trending-in-2026 Health Review Macao en PressRelease 2026-04-23T14:26:07+00:00 Mother’s Day Gift Ideas for Moms: Experiential Gifts Like Cooking Together Trending in 2026 https://ml.globenewswire.com/media/N2IwYmVlZjktN2JjOC00Njk5LWIxZmEtMzJhMGQwZWZjYzVlLTEzMjI2OTEtMjAyNi0wNC0yMy1lbg==/tiny/Raddish-Kids-Inc-.png https://healthreviewmacao.com/article/907546830-the-center-for-cancer-and-blood-disorders-receives-authorization-to-administer-fda-approved-car-t-cell-therapy-begins-treating-first-community Health Review Macao en PressRelease 2026-04-23T14:05:00+00:00 The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic https://ml.globenewswire.com/media/bb25f585-c65f-49ae-833e-6a3c04e2e01c/medium/the-center-for-cancer-and-blood-disorders-receives-authoriza.png https://healthreviewmacao.com/article/907549514-verano-founder-and-chief-executive-officer-george-archos-celebrates-historic-announcement-confirming-cannabis-rescheduling-to-schedule-iii Health Review Macao en PressRelease 2026-04-23T13:55:00+00:00 Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://healthreviewmacao.com/article/907549410-jushi-holdings-inc-applauds-president-trump-and-administration-for-delivering-on-cannabis-rescheduling-to-schedule-iii-under-the-controlled Health Review Macao en PressRelease 2026-04-23T13:43:18+00:00 Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://healthreviewmacao.com/article/907547420-lumina-therapy-alliance-expands-silicon-valley-presence-with-addition-of-wise-mind-institute-in-redwood-city-ca Health Review Macao en PressRelease 2026-04-23T13:40:00+00:00 Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA https://ml.globenewswire.com/media/046b4a15-6585-4d91-936e-8041854f2835/small/lumina-logo-li-1-png.png https://healthreviewmacao.com/article/907548326-innocare-releases-2026-q1-results-strong-revenue-growth-and-sustained-profitability Health Review Macao en PressRelease 2026-04-23T13:20:49+00:00 InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://healthreviewmacao.com/article/907545780-women-are-ditching-generic-diets-for-cycle-based-wellness-this-cycle-diet-app-review-explains-why Health Review Macao en PressRelease 2026-04-23T13:15:00+00:00 Women Are Ditching Generic Diets for Cycle-Based Wellness – This Cycle Diet App Review Explains Why https://ml-eu.globenewswire.com/media/70993e65-50d6-4174-b0c0-529713dd084f/medium/cycle-diet-cycle-based-weight-loss-program.png https://healthreviewmacao.com/article/907548102-leading-kidney-organizations-unite-on-capitol-hill-for-kidney-diseases-the-hidden-crisis-in-american-health-care-congressional-briefing Health Review Macao en PressRelease 2026-04-23T13:14:54+00:00 Leading Kidney Organizations Unite on Capitol Hill for “Kidney Diseases: The Hidden Crisis in American Health Care” Congressional Briefing https://ml.globenewswire.com/media/MjQwZmE4YjctZmI0OS00NTljLThhY2MtMTM5ZmNiNjdiYzYxLTExMDkwNTItMjAyNi0wNC0yMy1lbg==/tiny/American-Kidney-Fund.png https://healthreviewmacao.com/article/907538473-alpha-tau-announces-fda-approval-of-ide-supplement-to-expand-alpha-dart-impact-trial-to-patients-with-pancreatic-cancer-receiving-gemcitabine-with Health Review Macao en PressRelease 2026-04-23T13:02:00+00:00 Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel) https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://healthreviewmacao.com/article/907536253-alpha-tau-successfully-treats-first-pancreatic-cancer-patient-in-europe-with-alpha-dart-in-french-multicenter-acapella-clinical-trial Health Review Macao en PressRelease 2026-04-23T13:01:00+00:00 Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://healthreviewmacao.com/article/907526664-philips-launches-new-bridge-plus-occlusion-balloon-to-help-manage-rare-but-life-threatening-svc-tears-during-lead-extraction Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://healthreviewmacao.com/article/907529427-neura-health-to-expand-access-to-migraine-care-via-lillydirect Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Neura Health to Expand Access to Migraine Care via LillyDirect https://ml.globenewswire.com/media/306a1f86-8530-49f8-aa6b-3c6364cbcde1/small/neura-logo-png.png https://healthreviewmacao.com/article/907531469-neocis-and-yomi-s-named-winner-of-the-2026-tag-awards-for-medtech-in-robotic-procedural-innovation Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Neocis and Yomi® S Named Winner of the 2026 TAG Awards for MedTech in Robotic & Procedural Innovation https://ml.globenewswire.com/media/b2a5a1e1-cc7c-4d46-8ac3-c0f2a3682be2/small/neocis-alternate-png.png https://healthreviewmacao.com/article/907532046-dogwood-therapeutics-announces-worldwide-development-and-commercialization-partnership-for-anti-viral-assets-with-potential-value-up-to-100m Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M https://ml.globenewswire.com/media/7fe5cc47-6599-477c-a858-0f0d9b9f7eb5/small/green-and-gray-png.png https://healthreviewmacao.com/article/907532364-connect-biopharma-announces-enrollment-in-phase-2-seabreeze-stat-studies-will-continue-as-planned-following-pre-specified-interim-analysis Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis https://ml.globenewswire.com/media/831dcc2a-691d-4cad-813e-855f9fa2bd69/small/connect-logo-cmyk-jpg.jpg https://healthreviewmacao.com/article/907532701-maps-celebrates-40-years-at-a-defining-moment-for-psychedelics Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 MAPS Celebrates 40 Years at a Defining Moment for Psychedelics https://ml.globenewswire.com/media/4f774750-4742-4818-be22-116e2b2085b1/small/maps-logo-2021-primary-horizontal-white-background-1200x486.jpg https://healthreviewmacao.com/article/907534875-codexis-to-report-first-quarter-2026-financial-results-on-may-7 Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Codexis to Report First Quarter 2026 Financial Results on May 7 https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://healthreviewmacao.com/article/907538601-h1-launches-site-network-suite-the-first-ai-powered-platform-to-transform-how-research-sites-and-sponsors-engage-on-clinical-trials Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 H1 Launches Site Network Suite, the First AI-Powered Platform to Transform How Research Sites and Sponsors Engage on Clinical Trials https://ml.globenewswire.com/media/dc362fcf-5008-429c-bf37-cf26402cd802/small/h1-logo-primary-4x-21-png.png https://healthreviewmacao.com/article/907538664-heald-partners-with-thatch-marketplace-to-bring-first-of-its-kind-diabetes-reversal-program-to-employees Health Review Macao en PressRelease 2026-04-23T13:00:00+00:00 Heald Partners with Thatch Marketplace to Bring First-of-its-Kind Diabetes Reversal Program to Employees https://ml.globenewswire.com/media/5ed5f22c-5871-49c8-b232-ab058a530369/small/heald-logo-2-png.png https://healthreviewmacao.com/article/907538714-tilray-brands-positioned-for-u-s-expansion-amid-historic-cannabis-rescheduling Health Review Macao en PressRelease 2026-04-23T12:53:52+00:00 Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://healthreviewmacao.com/article/907530858-ritedose-university-of-south-carolina-welcome-top-european-business-students-for-immersive-learning-about-advanced-manufacturing Health Review Macao en PressRelease 2026-04-23T12:37:00+00:00 Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing https://ml.globenewswire.com/media/7d397bb5-f152-4003-abe7-88a69feaf034/medium/ritedose-university-in-action.jpg https://healthreviewmacao.com/article/907527341-vericel-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/6a144258-8523-493f-8a1e-ccceec233208/small/vericel-corporation-logo.jpg https://healthreviewmacao.com/article/907527777-icu-medical-announces-time-of-first-quarter-2026-earnings-conference-call Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call https://ml.globenewswire.com/media/44f52bc4-1355-405c-bdac-609254095f19/small/icu-medical-logo-jpg.jpg https://healthreviewmacao.com/article/907530786-cytodyn-to-host-investor-webcast Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 CytoDyn to Host Investor Webcast https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://healthreviewmacao.com/article/907531167-renovorx-announces-pharmacokinetic-and-pharmacodynamic-data-abstract-supporting-the-tamp-therapy-platform-accepted-for-presentation-at-the-2026-asco Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://healthreviewmacao.com/article/907531450-ss-innovations-unveils-cutting-edge-surgical-robotic-technologies-at-smrsc-2026 Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026 https://ml.globenewswire.com/media/5ab9180b-915c-4e02-838c-f5a9e458e61d/medium/ssi-vimana-aero-drone-system.png https://healthreviewmacao.com/article/907531754-enlivex-to-present-phase-iia-3-month-and-6-month-data-of-allocetra-at-oarsi-2026-world-congress Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://healthreviewmacao.com/article/907531972-polaryx-therapeutics-to-participate-in-national-tay-sachs-allied-diseases-association-annual-family-conference Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://healthreviewmacao.com/article/907535034-oncotelic-therapeutics-inc-otcqb-otlc-real-world-example-of-scientific-advancement-influence-on-evaluation Health Review Macao en PressRelease 2026-04-23T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://healthreviewmacao.com/article/907531463-moleculin-s-annamycin-extends-survival-by-more-than-60-in-metastatic-pancreatic-cancer-preclinical-models-data-presented-at-aacr-2026 Health Review Macao en PressRelease 2026-04-23T12:25:00+00:00 Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026 https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://healthreviewmacao.com/article/907531366-noom-health-s-smartrx-program-on-track-to-cut-employer-s-glp-1-spend-by-nearly-80 Health Review Macao en PressRelease 2026-04-23T12:01:00+00:00 Noom Health’s SmartRx Program on Track to Cut Employer’s GLP-1 Spend by Nearly 80% https://ml.globenewswire.com/media/MjVlZDBjOGYtYzVjZC00ZDkxLWE1NTItMmY3MjQzNDczOTNjLTEyMTc3NDctMjAyNi0wNC0yMy1lbg==/tiny/Noom-Inc.png https://healthreviewmacao.com/article/907537792-ardelyx-announces-abstract-exploring-ibs-c-treatment-patterns-accepted-for-poster-presentation-at-digestive-disease-week-2026 Health Review Macao en PressRelease 2026-04-23T12:01:00+00:00 Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://healthreviewmacao.com/article/907527434-collegium-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg https://healthreviewmacao.com/article/907528111-apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2026-financial-results-on-may-7-2026 Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/aa0687d3-ab28-4615-b1e7-ef6c6e2a5541/small/apyx-medical-logo-jpg.jpg https://healthreviewmacao.com/article/907528957-electrocore-product-line-featured-in-documentary-underscoring-the-expanding-clinical-and-commercial-role-of-vagus-nerve-stimulation Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://healthreviewmacao.com/article/907529926-mbx-biosciences-to-host-in-person-and-virtual-obesity-day-on-may-11-2026-to-discuss-expanding-obesity-portfolio Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio https://ml.globenewswire.com/media/5499b327-bce0-4a3f-96a7-04a38b68a99f/small/mbx-logos-final-full-jpg.jpg https://healthreviewmacao.com/article/907530330-atsena-therapeutics-announces-upcoming-presentations-at-scientific-and-medical-meetings Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Atsena Therapeutics Announces Upcoming Presentations at Scientific and Medical Meetings https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://healthreviewmacao.com/article/907533502-nanox-signs-distribution-agreement-with-radiology-oncology-systems-to-expand-nanox-arc-adoption-in-the-united-states Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg https://healthreviewmacao.com/article/907533837-reviva-to-participate-in-a-fireside-chat-hosted-by-a-g-p-on-brilaroxazine-s-potential-across-multiple-neuropsychiatric-indications Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications https://ml.globenewswire.com/media/1d8c6564-1da5-4561-b6ec-79de6d565869/small/reviva-logo-png.png https://healthreviewmacao.com/article/907536072-theialife-appoints-thomas-ruggia-as-president-and-chief-executive-officer-to-advance-phase-3-ready-oral-myopia-therapy-and-scale-ophthalmology Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform https://ml.globenewswire.com/media/7d66d72f-7dd8-41c5-8f9a-f17bf09572c6/small/theialife-logo-png.png https://healthreviewmacao.com/article/907537011-belite-bio-to-participate-in-four-upcoming-investor-conferences Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 Belite Bio to Participate in Four Upcoming Investor Conferences https://ml.globenewswire.com/media/7f86ac70-6347-41c6-a622-e7000c42ad35/small/belite-bio-logo-digital-full-color-png.png https://healthreviewmacao.com/article/907537024-cortec-s-brain-interchange-accepted-into-fda-total-product-life-cycle-advisory-program-tap Health Review Macao en PressRelease 2026-04-23T12:00:00+00:00 CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP) https://ml.globenewswire.com/media/b24bcd60-c029-415f-bcfd-277fade5e278/small/cortec-logo-tm-sub-rgb-transp-png.png https://healthreviewmacao.com/article/907528164-gb-healthwatch-launches-ai-ready-genetic-reports-for-the-gb-longevity100-suite Health Review Macao en PressRelease 2026-04-23T11:47:00+00:00 GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite https://ml.globenewswire.com/media/fccad032-0535-44e1-b7f1-b846db3ea3b7/medium/genomics-ai-for-longevity.jpg https://healthreviewmacao.com/article/907529388-marvel-biosciences-to-participate-and-present-at-the-2nd-neuroscience-innovation-partnering-and-licensing-summit Health Review Macao en PressRelease 2026-04-23T11:30:00+00:00 Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit https://ml.globenewswire.com/media/d49e32dc-88d9-4694-a3dd-6e663548e80d/small/picture1-png.png https://healthreviewmacao.com/article/907529549-plus-therapeutics-initiates-manufacturing-activities-with-spectronrx-under-a-master-services-agreement-to-support-gmp-pivotal-trial-readiness-for Health Review Macao en PressRelease 2026-04-23T11:30:00+00:00 Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™ https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://healthreviewmacao.com/article/907531773-corvus-pharmaceuticals-appoints-andrew-c-chan-m-d-ph-d-to-board-of-directors Health Review Macao en PressRelease 2026-04-23T11:30:00+00:00 Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://healthreviewmacao.com/article/907532602-helus-pharma-strengthens-scientific-advisory-board-with-addition-of-dr-robert-langer-and-dr-stephen-brannan Health Review Macao en PressRelease 2026-04-23T11:30:00+00:00 Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://healthreviewmacao.com/article/907530935-aurora-spine-corporation-schedules-release-of-fourth-quarter-and-fiscal-2025-financial-results Health Review Macao en PressRelease 2026-04-23T11:15:00+00:00 Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results https://ml.globenewswire.com/media/af1a0a7b-b883-41f9-8c86-a89bad3cc4a4/small/aurora12-jpg.JPG https://healthreviewmacao.com/article/907529456-the-joint-corp-to-report-2026-first-quarter-results-on-thursday-may-7-and-host-conference-call-and-webcast Health Review Macao en PressRelease 2026-04-23T11:05:00+00:00 The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast https://ml.globenewswire.com/media/ca375acf-3959-4292-8efa-e64eeeca3ed0/small/jynt-792x612px-1-png.png https://healthreviewmacao.com/article/907530793-ocugen-to-present-at-april-2026-investor-and-industry-conferences Health Review Macao en PressRelease 2026-04-23T11:02:00+00:00 Ocugen to Present at April 2026 Investor and Industry Conferences https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://healthreviewmacao.com/article/907526315-radiopharm-theranostics-reports-business-update Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Radiopharm Theranostics Reports Business Update https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png https://healthreviewmacao.com/article/907526650-genenta-signs-definitive-agreements-with-sophia-high-tech Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Genenta signs Definitive Agreements with Sophia High Tech https://ml-eu.globenewswire.com/media/512cd33c-8299-4f88-9053-ae862103eb0e/small/genenta-logo-positivo-png.png https://healthreviewmacao.com/article/907526659-antag-therapeutics-to-present-data-on-at7687-its-first-in-class-gipr-antagonist-peptide-at-the-american-diabetes-association-s-2026-scientific Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions https://ml-eu.globenewswire.com/media/5001e437-9bc0-482c-9bee-3be9c9f71505/small/antag-logo-black-rgb-jpg.jpg https://healthreviewmacao.com/article/907528725-kymera-therapeutics-to-report-first-quarter-2026-financial-results-on-april-30-2026 Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026 https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://healthreviewmacao.com/article/907529147-tonix-pharmaceuticals-presents-updates-on-preclinical-immuno-oncology-programs-at-the-american-association-for-cancer-research-aacr-annual-meeting Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026 https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://healthreviewmacao.com/article/907529376-aafa-highlights-new-resources-for-nasal-polyps-in-recognition-of-global-crswnp-awareness-day Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 AAFA Highlights New Resources for Nasal Polyps in Recognition of Global CRSwNP Awareness Day https://ml.globenewswire.com/media/ZGIxMDA1MTUtZWIyZi00MmRkLWEzNzctNzY5NGI2ZWY4MTU3LTExMDE5NjItMjAyNi0wNC0yMy1lbg==/tiny/Asthma-and-Allergy-Foundation-.png https://healthreviewmacao.com/article/907530148-conavi-medical-awarded-2026-tag-innovation-award Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Conavi Medical Awarded 2026 TAG Innovation Award https://ml.globenewswire.com/media/4a28f1c0-f99d-4940-b2a7-201ab98cdaff/small/conavi-jpg.jpg https://healthreviewmacao.com/article/907530670-jade-biosciences-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://healthreviewmacao.com/article/907530835-psyence-biomed-initiates-patient-dosing-in-phase-iib-trial-evaluating-npx-5-for-adjustment-disorder Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder https://ml.globenewswire.com/media/256a2527-4c30-46a1-a4d4-f37c89cfbff2/small/psyence-logo-jpg.jpg https://healthreviewmacao.com/article/907531417-verano-expands-retail-presence-on-florida-s-emerald-coast-with-opening-of-m-v-miramar-beach-the-company-s-85th-florida-dispensary-and-162nd-location Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Verano Expands Retail Presence on Florida’s Emerald Coast with Opening of MÜV Miramar Beach, the Company’s 85th Florida Dispensary and 162nd Location Nationwide https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://healthreviewmacao.com/article/907532361-brewdog-usa-doubles-down-on-headliners-and-ignites-next-wave-of-innovation-for-spring-and-summer Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer https://ml.globenewswire.com/media/d423c9fd-1d8f-4ea0-bf36-4f5c40fa13e7/medium/brewdog-elvis-juice.jpg https://healthreviewmacao.com/article/907532569-validic-launches-free-developer-tier-with-api-driven-agentic-ready-self-signup Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Validic Launches Free Developer Tier with API-Driven, Agentic-Ready Self-Signup https://ml.globenewswire.com/media/5c89ea69-9ba7-4994-a816-9e0fe1f95b46/small/validic-logo-jpg.jpg https://healthreviewmacao.com/article/907535459-transcenta-therapeutics-presents-new-data-for-its-novel-liv1-targeting-adc-tst013-demonstrating-potent-anti-tumor-activity-in-pdx-models-of-prostate Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer https://ml.globenewswire.com/media/N2E2ZDY4ZjItMTU5My00ZTQ3LTkzZWUtZjdmMDFjODNkOGVjLTEzMDM2NDAtMjAyNi0wNC0yMy1lbg==/tiny/Transcenta.png https://healthreviewmacao.com/article/907535959-aavantgarde-to-participate-in-arvo-2026-with-presentations-at-key-pre-events-and-new-clinical-data-from-the-luce-phase-1-2-study Health Review Macao en PressRelease 2026-04-23T11:00:00+00:00 AAVantgarde to Participate in ARVO 2026, with Presentations at Key Pre-events and New Clinical Data from the LUCE Phase 1/2 Study https://ml.globenewswire.com/media/e7ffd915-8158-436d-b9fe-8db1cb3597ce/small/logo-png.png https://healthreviewmacao.com/article/907507667-aveanna-announces-first-quarter-2026-earnings-release-date-and-conference-call Health Review Macao en PressRelease 2026-04-23T10:30:00+00:00 Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png https://healthreviewmacao.com/article/907508353-greenwich-lifesciences-announces-acceptance-of-abstract-at-asco-2026 Health Review Macao en PressRelease 2026-04-23T10:00:00+00:00 Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://healthreviewmacao.com/article/907489700-epitopea-announces-approval-of-ovact-clinical-trial-application-for-cryptivax-1001-in-advanced-high-grade-serous-ovarian-cancer Health Review Macao en PressRelease 2026-04-23T08:00:00+00:00 Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer https://ml.globenewswire.com/media/e42e44d9-eec5-4ff3-a9ee-fab395efd2a8/small/epitopea-instagram-post-2-jpg.jpg https://healthreviewmacao.com/article/907489827-nectero-therapeutics-reports-two-year-safety-and-efficacy-data-from-first-in-human-trial-for-treatment-of-small-to-medium-sized-abdominal-aortic Health Review Macao en PressRelease 2026-04-23T08:00:00+00:00 Nectero Therapeutics Reports Two-Year Safety and Efficacy Data from First-in-Human Trial for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms https://ml.globenewswire.com/media/925156fd-7767-4c7b-b969-3584da050fbb/small/nectero-therapeutics-logo-horizontal-centered-png.png https://healthreviewmacao.com/article/907489911-ena-respiratory-appoints-melissa-faris-to-board Health Review Macao en PressRelease 2026-04-23T08:00:00+00:00 ENA Respiratory Appoints Melissa Faris to Board https://ml-eu.globenewswire.com/media/84159208-c519-49a5-86c6-56151e3ab92b/small/ena-png.png https://healthreviewmacao.com/article/907490272-epitopea-annonce-l-approbation-de-la-demande-d-essai-clinique-ovact-pour-le-cryptivax-1001-dans-le-cancer-de-l-ovaire-s-reux-de-haut-grade-avanc Health Review Macao en PressRelease 2026-04-23T08:00:00+00:00 Epitopea annonce l'approbation de la demande d'essai clinique OVACT pour le CryptiVax-1001 dans le cancer de l'ovaire séreux de haut grade avancé https://ml.globenewswire.com/media/e42e44d9-eec5-4ff3-a9ee-fab395efd2a8/small/epitopea-instagram-post-2-jpg.jpg https://healthreviewmacao.com/article/907490040-last-patient-last-visit-completed-in-phase-i-clinical-trial-of-pulsesight-therapeutics-pst-611-treatment-for-dry-amd-geographic-atrophy-ga Health Review Macao en PressRelease 2026-04-23T07:00:00+00:00 Last patient, last visit completed in Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA) https://ml-eu.globenewswire.com/media/9f8ee53c-2465-4c3c-870e-4077c6a39edb/small/pulsesight-therapeutics-logo-horizontal-full-gradient-mark-0.png https://healthreviewmacao.com/article/907473525-orion-pharma-initiates-teadco-phase-1b-2-basket-trial-evaluating-odm-212-in-combination-with-standard-of-care-treatments-in-patients-with-select Health Review Macao en PressRelease 2026-04-23T06:00:00+00:00 Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://healthreviewmacao.com/article/907473565-orion-pharma-on-aloittanut-teadco-faasi-1b-2-tutkimuksen-odm-212-molekyylill-yhdess-vakiintuneiden-hoitojen-kanssa-potilailla-joilla-on-tiettyj Health Review Macao en PressRelease 2026-04-23T06:00:00+00:00 Orion Pharma on aloittanut TEADCO Faasi 1b/2 -tutkimuksen ODM-212-molekyylillä yhdessä vakiintuneiden hoitojen kanssa potilailla, joilla on tiettyjä pitkälle edenneitä kiinteitä kasvaimia https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://healthreviewmacao.com/article/907472537-ose-immunotherapeutics-annonce-la-pr-sentation-des-r-sultats-de-l-tude-de-phase-2-tedova-de-tedopi-dans-le-cancer-de-l-ovaire-au-congr-s-2026-de Health Review Macao en PressRelease 2026-04-23T05:30:00+00:00 OSE Immunotherapeutics annonce la présentation des résultats de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire au Congrès 2026 de l’ASCO https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://healthreviewmacao.com/article/907472704-communiqu-de-presse-t1-2026-croissance-deux-chiffres-du-chiffre-d-affaires-et-du-bnpa Health Review Macao en PressRelease 2026-04-23T05:30:00+00:00 Communiqué de presse : T1 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://healthreviewmacao.com/article/907472829-ose-immunotherapeutics-announces-presentation-of-tedova-phase-2-topline-results-of-tedopi-in-ovarian-cancer-at-the-asco-2026-meeting Health Review Macao en PressRelease 2026-04-23T05:30:00+00:00 OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://healthreviewmacao.com/article/907473075-press-release-q1-2026-double-digit-sales-and-business-eps-growth Health Review Macao en PressRelease 2026-04-23T05:30:00+00:00 Press Release: Q1 2026: double-digit sales and business EPS growth https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://healthreviewmacao.com/article/907472300-santhera-ernennt-orlando-oliveira-zum-chief-executive-officer Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Santhera ernennt Orlando Oliveira zum Chief Executive Officer https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://healthreviewmacao.com/article/907472306-santhera-appoints-orlando-oliveira-as-chief-executive-officer Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Santhera Appoints Orlando Oliveira as Chief Executive Officer https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://healthreviewmacao.com/article/907473115-ipsen-delivers-strong-sales-in-the-first-quarter-of-2026-and-confirms-its-full-year-guidance Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Ipsen delivers strong sales in the first quarter of 2026 and confirms its full-year guidance https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://healthreviewmacao.com/article/907473136-ipsen-enregistre-une-forte-croissance-de-ses-ventes-au-premier-trimestre-2026-et-confirme-ses-objectifs-annuels Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Ipsen enregistre une forte croissance de ses ventes au premier trimestre 2026 et confirme ses objectifs annuels https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ https://healthreviewmacao.com/article/907473143-addex-spin-out-company-neurosterix-on-track-to-complete-phase-1-clinical-study-of-ntx-253-for-schizophrenia-in-q2-2026 Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026 https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://healthreviewmacao.com/article/907473584-nobelpreisverd-chtige-entdeckung-von-vectorbuilder-wissenschaftlern-deckt-grundlegende-entwicklungsmechanismen-auf Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Nobelpreisverdächtige Entdeckung von VectorBuilder-Wissenschaftlern deckt grundlegende Entwicklungsmechanismen auf https://ml.globenewswire.com/media/051ef275-dc49-4fe6-bf1c-5736d994e6d3/small/vectorbuilder-logo-en-png.png https://healthreviewmacao.com/article/907473586-une-d-couverte-susceptible-de-valoir-un-prix-nobel-par-les-scientifiques-de-vectorbuilder-r-v-le-les-m-canismes-fondamentaux-du-d-veloppement Health Review Macao en PressRelease 2026-04-23T05:00:00+00:00 Une découverte susceptible de valoir un prix Nobel par les scientifiques de VectorBuilder révèle les mécanismes fondamentaux du développement https://ml.globenewswire.com/media/051ef275-dc49-4fe6-bf1c-5736d994e6d3/small/vectorbuilder-logo-en-png.png https://healthreviewmacao.com/article/907454943-new-funding-opportunities-pave-the-way-for-better-diagnostics-and-treatment-as-well-as-for-engineering-efficient-biosolutions-and-replacing-critical Health Review Macao en PressRelease 2026-04-23T04:30:00+00:00 New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources https://ml-eu.globenewswire.com/media/MTU3MDQwYzAtNDM3Ni00MDRkLWI0ZGMtNGY5N2VmMDczMDM4LTcwMDAyNzU2OC0yMDI2LTA0LTIzLWVu/tiny/Novo-Nordisk-Foundation.png https://healthreviewmacao.com/article/907455370-altimmune-announces-pricing-of-225-million-oversubscribed-public-offering-of-securities Health Review Macao en PressRelease 2026-04-23T03:25:00+00:00 Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://healthreviewmacao.com/article/907421195-exicure-announces-co-development-agreement-with-adbiotech-for-burixafor-gpc-100 Health Review Macao en PressRelease 2026-04-22T23:54:21+00:00 Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) https://ml.globenewswire.com/media/3a5f958d-422c-4a97-a96d-cf06f640b587/small/exicure-logo-final-full-color-072515-png.png https://healthreviewmacao.com/article/907404570-press-release-sanofi-and-regeneron-s-dupixent-approved-in-the-us-as-the-first-biologic-medicine-for-young-children-with-uncontrolled-chronic Health Review Macao en PressRelease 2026-04-22T21:30:00+00:00 Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://healthreviewmacao.com/article/907404644-communiqu-de-presse-dupixent-d-velopp-par-sanofi-et-regeneron-a-t-approuv-aux-tats-unis-comme-tant-le-premier-m-dicament-biologique-pour Health Review Macao en PressRelease 2026-04-22T21:30:00+00:00 Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://healthreviewmacao.com/article/907406205-dupixent-dupilumab-approved-in-the-u-s-as-the-first-biologic-medicine-for-young-children-with-uncontrolled-chronic-spontaneous-urticaria-csu Health Review Macao en PressRelease 2026-04-22T21:30:00+00:00 Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU) https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://healthreviewmacao.com/article/907404484-george-medicines-new-england-journal-of-medicine-publishes-global-stroke-outcomes-trial-that-demonstrated-reduction-of-risk-for-recurrent-stroke-by Health Review Macao en PressRelease 2026-04-22T21:00:00+00:00 George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage https://ml-eu.globenewswire.com/media/96c66748-e7e2-4d1b-9950-2dbc75f2be98/small/george-medicines-logo-jpg.JPG https://healthreviewmacao.com/article/907405686-greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing Health Review Macao en PressRelease 2026-04-22T21:00:00+00:00 Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://healthreviewmacao.com/article/907405515-sight-sciences-announces-the-release-of-its-sustainability-report Health Review Macao en PressRelease 2026-04-22T20:45:00+00:00 Sight Sciences Announces the Release of its Sustainability Report https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://healthreviewmacao.com/article/907389765-plus-therapeutics-reports-granting-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Health Review Macao en PressRelease 2026-04-22T20:30:00+00:00 Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://healthreviewmacao.com/article/907392165-altimmune-announces-proposed-underwritten-public-offering-of-securities Health Review Macao en PressRelease 2026-04-22T20:19:41+00:00 Altimmune Announces Proposed Underwritten Public Offering of Securities https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://healthreviewmacao.com/article/907389823-dentsply-sirona-to-host-first-quarter-2026-conference-call-on-may-5 Health Review Macao en PressRelease 2026-04-22T20:15:00+00:00 Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5 https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG https://healthreviewmacao.com/article/907390739-silo-pharma-announces-strategic-business-expansion-into-multi-billion-dollar-ai-agent-market-with-acquisition-of-managed-ai-agent-platform-qwikagents Health Review Macao en PressRelease 2026-04-22T20:15:00+00:00 Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png https://healthreviewmacao.com/article/907391236-supernus-pharmaceuticals-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-may-5-2026 Health Review Macao en PressRelease 2026-04-22T20:15:00+00:00 Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026 https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://healthreviewmacao.com/article/907389885-rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6 Health Review Macao en PressRelease 2026-04-22T20:10:00+00:00 RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://healthreviewmacao.com/article/907390905-orasure-to-announce-first-quarter-2026-financial-results-and-host-earnings-call-on-may-6th Health Review Macao en PressRelease 2026-04-22T20:10:00+00:00 OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th https://ml.globenewswire.com/media/713ef28e-6d0b-4156-a92f-397061b474cf/small/oti-wordmark-png.png https://healthreviewmacao.com/article/907389412-abivax-to-present-data-on-obefazimod-at-digestive-disease-week Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 Abivax to Present Data on Obefazimod at Digestive Disease Week® https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://healthreviewmacao.com/article/907389490-skinhealth-systems-inc-appoints-three-new-independent-directors-to-board Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 SkinHealth Systems Inc. Appoints Three New Independent Directors to Board https://ml.globenewswire.com/media/187132d2-7aef-4a14-8cd2-07829cc11496/small/skinhealthsystems-logo-black-jpg.jpg https://healthreviewmacao.com/article/907389686-lifecore-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png https://healthreviewmacao.com/article/907389732-petmeds-announces-strategic-partnership-with-rural-king-to-launch-pet-pharmacy-offering-across-retail-and-digital-channels Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels https://ml.globenewswire.com/media/dac159be-c4f9-491f-baa3-811a3ee58631/small/petmeds-pm-green-png.png https://healthreviewmacao.com/article/907389826-bbot-presents-preclinical-data-demonstrating-pan-kras-inhibitor-bbo-11818-has-robust-anti-tumor-activity-in-kras-mutant-preclinical-models-at-the-aacr Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026 https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://healthreviewmacao.com/article/907389875-lb-pharmaceuticals-announces-publication-in-jama-psychiatry-of-results-from-phase-2-nova-1-trial-of-lb-102-in-schizophrenia Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia https://ml.globenewswire.com/media/90903161-520e-409f-b2ac-dd18677b4bb8/small/lb-pharma-logo-png.png https://healthreviewmacao.com/article/907391198-tomi-environmental-solutions-scales-automation-with-steramist-ihp-robot-upgrade-targets-fast-growing-robotaxi-market Health Review Macao en PressRelease 2026-04-22T20:05:00+00:00 TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://healthreviewmacao.com/article/907390887-teknova-to-report-first-quarter-2026-financial-results-on-may-6-2026 Health Review Macao en PressRelease 2026-04-22T20:01:00+00:00 Teknova to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/b4992253-8b06-4ba7-93c8-e1f9938c6556/small/updated-teknova-logo-2023-png.png https://healthreviewmacao.com/article/907389326-inventiva-strengthens-leadership-team-ahead-of-expected-phase-3-data-readout-of-lanifibranor Health Review Macao en PressRelease 2026-04-22T20:00:00+00:00 Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg https://healthreviewmacao.com/article/907389620-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated Health Review Macao en PressRelease 2026-04-22T20:00:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://healthreviewmacao.com/article/907389682-inventiva-renforce-son-quipe-de-direction-l-approche-des-r-sultats-de-phase-3-du-lanifibranor Health Review Macao en PressRelease 2026-04-22T20:00:00+00:00 Inventiva renforce son équipe de direction à l’approche des résultats de Phase 3 du lanifibranor https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/ https://healthreviewmacao.com/article/907390953-canadian-association-of-occupational-therapy-calls-for-expansion-of-canada-student-loan-forgiveness-program-to-include-occupational-therapy Health Review Macao en PressRelease 2026-04-22T19:07:17+00:00 Canadian Association of Occupational Therapy Calls for Expansion of Canada Student Loan Forgiveness Program to Include Occupational Therapy https://ml.globenewswire.com/media/OTY4MjVlNTktZmQzYS00ZTNlLWE4MGYtOTlkNzFhMDBhZjhiLTEyNzEzMzEtMjAyNi0wNC0yMi1lbg==/tiny/Canadian-Association-of-Occupa.png https://healthreviewmacao.com/article/907375714-san-francisco-49ers-choose-sutter-health-as-official-healthcare-partner-connecting-millions-to-prevention-and-wellness Health Review Macao en PressRelease 2026-04-22T18:30:00+00:00 San Francisco 49ers Choose Sutter Health as Official Healthcare Partner, Connecting Millions to Prevention and Wellness https://ml.globenewswire.com/media/NjI2ODQ0ZjktMTc4MS00ODZlLWFlMDMtODY1MTY0YjIzMTc2LTUwMDE1MDYxNS0yMDI2LTA0LTIyLWVu/tiny/Sutter-Health.png https://healthreviewmacao.com/article/907376567-mind-lab-pro-unveiled-does-this-universal-nootropic-really-improve-focus-memory-brain-power-read-mind-lab-pro-report Health Review Macao en PressRelease 2026-04-22T17:52:47+00:00 Mind Lab Pro Unveiled: Does This “Universal Nootropic” Really Improve Focus, Memory & Brain Power? Read Mind Lab PRO Report! https://ml.globenewswire.com/media/7256714c-3c34-4b41-b0a9-f9ed47a244b4/medium/mind-lab-pro.png https://healthreviewmacao.com/article/907375796-romeo-orthopaedics-welcomes-lauren-hennessy-mpas-pa-c-to-their-esteemed-team Health Review Macao en PressRelease 2026-04-22T17:24:00+00:00 Romeo Orthopaedics Welcomes Lauren Hennessy, MPAS, PA‑C, to Their Esteemed Team https://pressranger.s3.us-west-1.amazonaws.com/3235166/Romeo-Orthopaedics-Welcomes-Lauren-Hennessy.png https://healthreviewmacao.com/article/907375791-medshop-direct-expands-white-glove-delivery-and-installation-of-adjustable-medical-beds-for-assisted-living-and-home-care-across-48-states Health Review Macao en PressRelease 2026-04-22T17:14:00+00:00 MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States https://pressranger.s3.us-west-1.amazonaws.com/3235115/Adjustable-Beds-for-Seniors-and-Geriatric-Care.png https://healthreviewmacao.com/article/907362390-providence-saint-john-s-study-finds-lifestyle-program-improves-brain-health-in-patients-with-early-cognitive-impairment Health Review Macao en PressRelease 2026-04-22T16:00:00+00:00 Providence Saint John’s Study Finds Lifestyle Program Improves Brain Health in Patients with Early Cognitive Impairment https://ml.globenewswire.com/media/5cec38c7-016b-458b-b0cf-462a36e4f605/small/saintjohnshealthcenter-2l-clr-4cp-lowerres-jpg.jpg https://healthreviewmacao.com/article/907363292-columbia-university-fertility-center-weill-cornell-medicine-and-nyu-langone-fertility-center-named-among-america-s-best-fertility-clinics-2026-by Health Review Macao en PressRelease 2026-04-22T16:00:00+00:00 Columbia University Fertility Center, Weill Cornell Medicine, and NYU Langone Fertility Center Named Among America’s Best Fertility Clinics 2026 by Newsweek https://ml.globenewswire.com/media/ff894e2a-f8d8-4c34-976c-655561bd8c22/small/newsweek-logotype-rgb-black-1-png.png https://healthreviewmacao.com/article/907362712-joyce-university-expands-nursing-education-to-residents-in-indiana-and-florida Health Review Macao en PressRelease 2026-04-22T15:39:20+00:00 Joyce University Expands Nursing Education to Residents in Indiana and Florida https://ml.globenewswire.com/media/ODFlNTAxYjgtYjdkNC00YTVhLWExNzQtNTY5MWU2NGZmN2JhLTUwMDE2MDk1Mi0yMDI2LTA0LTIyLWVu/tiny/Joyce-University-of-Nursing-an.png https://healthreviewmacao.com/article/907351252-eso-and-iaed-launch-the-network-for-evidence-based-dispatch Health Review Macao en PressRelease 2026-04-22T15:31:16+00:00 ESO and IAED Launch the Network for Evidence-Based Dispatch https://ml.globenewswire.com/media/d2b1770b-b470-4e43-a635-c130cc6e0f59/small/eso-nebdlogo-final-png.png https://healthreviewmacao.com/article/907348889-netris-pharma-nature-publishes-positive-pancreatic-cancer-phase-1b-data-for-np137-anti-netrin-1-monoclonal-antibody Health Review Macao en PressRelease 2026-04-22T15:00:00+00:00 NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody https://ml-eu.globenewswire.com/media/dca1b4e9-d18b-4e3d-b301-c2b206e88591/small/netris-logo-jpg.jpg https://healthreviewmacao.com/article/907350560-hairclub-named-company-of-the-year-for-second-straight-year-as-turnaround-drives-growth-and-profitability Health Review Macao en PressRelease 2026-04-22T15:00:00+00:00 HairClub Named Company of the Year for Second Straight Year as Turnaround Drives Growth and Profitability https://ml.globenewswire.com/media/YmVmNjk4MDctOTE3ZS00MmI3LTlhNzQtNmM1MTRlNjdhYzZkLTUwMDE1MzY4OS0yMDI2LTA0LTIyLWVu/tiny/HairClub.png https://healthreviewmacao.com/article/907349027-companion-animal-diagnostics-market-to-reach-usd-5-40-billion-by-2031-marketsandmarkets Health Review Macao en PressRelease 2026-04-22T14:30:00+00:00 Companion Animal Diagnostics Market to Reach USD 5.40 Billion by 2031 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://healthreviewmacao.com/article/907349282-mindera-health-awarded-new-york-state-department-of-health-approval-for-mind-px Health Review Macao en PressRelease 2026-04-22T14:00:00+00:00 Mindera Health™ Awarded New York State Department of Health Approval for Mind.Px™ https://ml.globenewswire.com/media/YTU2MjQ5NzQtYWQxZS00M2JhLTgwODMtMjlkNWIwMDRjMWU1LTEyNzUwNjgtMjAyNi0wNC0yMi1lbg==/tiny/Mindera-Health.png https://healthreviewmacao.com/article/907335885-three-peat-becker-s-healthcare-dubs-u-s-oral-surgery-management-a-dso-to-know Health Review Macao en PressRelease 2026-04-22T13:45:00+00:00 Three-Peat: Becker’s Healthcare Dubs U.S. Oral Surgery Management a DSO to Know https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png https://healthreviewmacao.com/article/907335671-adial-pharmaceuticals-successfully-completes-manufacturing-of-demonstration-batch-production-enabling-clinical-and-registration-production-for-ad04 Health Review Macao en PressRelease 2026-04-22T13:35:00+00:00 Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial https://ml.globenewswire.com/media/e6fc09f7-5847-46c8-9294-f51162a7e518/small/adil-logo-png.png https://healthreviewmacao.com/article/907337391-nexalin-technology-advances-pivotal-clinical-trial-of-halo-clarity-toward-q2-2026-enrollment Health Review Macao en PressRelease 2026-04-22T13:35:00+00:00 Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://healthreviewmacao.com/article/907334786-lift-biosciences-announces-publication-of-review-article-in-frontiers-in-immunology-highlighting-broad-therapeutic-potential-of-neutrophils-and-imans Health Review Macao en PressRelease 2026-04-22T13:30:00+00:00 LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer https://ml-eu.globenewswire.com/media/de6a30f1-b2fb-4208-a4c8-e53b2c2184dc/small/lift-biosciences-logo-side-on-final-upscale-png.png https://healthreviewmacao.com/article/907341175-quantum-biopharma-licensee-unbuzzd-wellness-inc-appoints-richard-buzbuzian-as-ceo-to-lead-nationwide-commercialization-of-innovative-clinically Health Review Macao en PressRelease 2026-04-22T13:16:08+00:00 Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant https://ml.globenewswire.com/media/8b9aab62-d5e1-47c2-a1ce-834c390552e6/small/quantumbiopharma-logo-hires-2-jpg.jpg https://healthreviewmacao.com/article/907336782-perfectserve-ranks-1-across-all-use-cases-in-the-gartner-critical-capabilities-for-clinical-communication-and-collaboration-report Health Review Macao en PressRelease 2026-04-22T13:01:00+00:00 PerfectServe Ranks #1 Across All Use Cases in the Gartner® Critical Capabilities for Clinical Communication and Collaboration Report https://ml.globenewswire.com/media/3e4a399a-dcba-46ce-acdd-f708dafccf41/medium/perfectserve-is-1-across-all-critical-capabilities-use-cases.png https://healthreviewmacao.com/article/907334780-philips-receives-fda-510-k-clearance-for-its-rembra-platform-expanding-access-to-faster-more-precise-ct-imaging-across-frontline-care-and-cancer Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://healthreviewmacao.com/article/907335058-agora-and-thymia-partner-to-enable-real-time-health-and-safety-intelligence-across-voice-communications Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Agora and thymia Partner to Enable Real-Time Health and Safety Intelligence Across Voice Communications https://ml.globenewswire.com/media/5d0b71db-c424-433c-b190-ec8bf61ca1ca/small/agora-logo-rgb-blue-png.png https://healthreviewmacao.com/article/907336133-eleos-expands-ai-agents-across-the-full-care-journey Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Eleos Expands AI Agents Across the Full Care Journey https://ml.globenewswire.com/media/231b5a81-1485-459d-929d-c0fe63ecdf90/small/eleos-logo-cmyk-og-png.png https://healthreviewmacao.com/article/907336379-paragonix-announces-technology-upgrade-to-industry-leading-sherpapak-cardiac-transport-system Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Paragonix Announces Technology Upgrade to Industry Leading SherpaPak® Cardiac Transport System https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://healthreviewmacao.com/article/907336804-capricor-therapeutics-announces-late-breaking-presentation-of-hope-3-phase-3-results-at-the-american-academy-of-neurology-2026-annual-meeting Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png https://healthreviewmacao.com/article/907336882-bbot-announces-the-appointment-of-pedro-j-beltran-phd-as-chief-executive-officer-idan-elmelech-as-chief-operating-officer-and-neil-kumar-phd-as Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://healthreviewmacao.com/article/907336891-amae-health-and-novant-health-bring-enhanced-integrated-care-model-for-severe-mental-illness-to-charlotte-north-carolina Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina https://ml.globenewswire.com/media/f481cdb2-826e-41e4-b3c8-e15697dcee1b/medium/amae-health-novant-health.jpg https://healthreviewmacao.com/article/907337077-femasys-launches-femaseed-complete-for-ob-gyns-at-acog-2026 Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026 https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://healthreviewmacao.com/article/907337920-onemednet-goes-live-with-80-million-patient-journeys-and-billions-of-records Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records https://ml.globenewswire.com/media/a356ae1d-a3c0-49e3-81b5-f19be76513d0/small/onemednet-jpg.jpg https://healthreviewmacao.com/article/907340575-emblemhealth-expands-community-diabetes-wellness-program-bringing-free-citywide-support-to-new-yorkers Health Review Macao en PressRelease 2026-04-22T13:00:00+00:00 EmblemHealth Expands Community Diabetes Wellness Program, Bringing Free, Citywide Support to New Yorkers https://ml.globenewswire.com/media/3bf9ec00-7535-4b80-975a-7eafc2b55599/small/emb-logo-png.png https://healthreviewmacao.com/article/907336147-autonomix-medical-to-present-long-term-pain-mitigation-data-in-pancreatic-cancer-at-ecio-2026 Health Review Macao en PressRelease 2026-04-22T12:42:00+00:00 Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 https://ml.globenewswire.com/media/8b0ba1bc-43b1-4445-b895-712da30f7df8/small/logo-png.png https://healthreviewmacao.com/article/907339982-cue-biopharma-announces-1-for-30-reverse-stock-split Health Review Macao en PressRelease 2026-04-22T12:37:18+00:00 Cue Biopharma Announces 1-for-30 Reverse Stock Split https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://healthreviewmacao.com/article/907335149-wave-life-sciences-first-quarter-2026-financial-results-scheduled-for-april-28-2026 Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://healthreviewmacao.com/article/907335902-cytodyn-presents-new-leronlimab-data-in-metastatic-colorectal-cancer-at-aacr-annual-meeting-2026 Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://healthreviewmacao.com/article/907336154-microbot-medical-welcomes-updated-occupational-protection-guidelines-from-leading-medical-societies-strengthening-commercial-position-of-liberty Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://healthreviewmacao.com/article/907336432-spectral-ai-s-deepview-system-showcased-at-2026-american-burn-association-annual-meeting Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://healthreviewmacao.com/article/907336985-advancing-drug-pipelines-drive-biotech-valuations-as-scientific-progress-gains-financial-recognition Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://healthreviewmacao.com/article/907337081-aclarion-announces-2-5-million-stock-repurchase-plan Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 Aclarion Announces $2.5 Million Stock Repurchase Plan https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://healthreviewmacao.com/article/907338337-outlook-therapeutics-announces-5-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules Health Review Macao en PressRelease 2026-04-22T12:30:00+00:00 Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://healthreviewmacao.com/article/907337788-srx-health-solutions-invests-in-astro-investment-xvii-an-affiliate-of-astro-capital Health Review Macao en PressRelease 2026-04-22T12:20:00+00:00 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://healthreviewmacao.com/article/907322320-madrigal-pharmaceuticals-to-release-first-quarter-2026-financial-results-and-host-webcast-on-may-6-2026 Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026 https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://healthreviewmacao.com/article/907322372-pmv-pharmaceuticals-announces-board-chair-transition Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 PMV Pharmaceuticals Announces Board Chair Transition https://ml.globenewswire.com/media/856eb6a7-75a1-45e1-8b0e-e50c81bf0d62/small/pmv-logo-new-png.png https://healthreviewmacao.com/article/907322811-the-beauty-health-company-announces-corporate-rebrand-to-skinhealth-systems-reflecting-evolution-into-a-clinically-driven-science-backed-medical Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform https://ml.globenewswire.com/media/187132d2-7aef-4a14-8cd2-07829cc11496/small/skinhealthsystems-logo-black-jpg.jpg https://healthreviewmacao.com/article/907322932-opko-health-s-modex-therapeutics-begins-clinical-trial-of-tetraspecific-antibody-for-treatment-of-b-cell-lymphomas Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://healthreviewmacao.com/article/907322955-astiva-health-entered-april-2026-with-record-high-47-000-enrolled-members Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Astiva Health Entered April 2026 with Record High 47,000+ Enrolled Members https://ml.globenewswire.com/media/1f054d06-9b9c-406f-8695-fb35d37d034c/small/astiva-logo-png-png.png https://healthreviewmacao.com/article/907323131-mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29 Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29 https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://healthreviewmacao.com/article/907323198-cloudbreak-pharma-announces-presentation-on-its-multi-kinase-inhibition-mki-platform-and-ongoing-clinical-programs-at-eyecelerator-arvo-2026 Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026 https://ml.globenewswire.com/media/a68e17c2-8a7a-44cf-bf9d-22382ad4109d/small/cloudbreak-pharma-logo-file-png.png https://healthreviewmacao.com/article/907323304-humacyte-appoints-jim-mercadante-as-chief-commercial-officer Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Humacyte Appoints Jim Mercadante as Chief Commercial Officer https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://healthreviewmacao.com/article/907323314-corbus-pharmaceuticals-announces-abstracts-accepted-for-presentation-at-asco-2026-featuring-updated-clinical-data-for-crb-701 Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701 https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://healthreviewmacao.com/article/907323463-neurona-presents-updated-data-from-ongoing-clinical-trials-of-rezanecel-nrtx-1001-regenerative-cell-therapy-in-mesial-temporal-lobe-epilepsy-at-2026 Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting  https://ml.globenewswire.com/media/70107450-aa41-4000-952d-a7784836077d/small/logo-horizontal-fill-white-transparent-png.png https://healthreviewmacao.com/article/907323647-arcutis-zoryve-roflumilast-cream-receives-strong-recommendation-in-american-academy-of-dermatology-first-ever-pediatric-atopic-dermatitis Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://healthreviewmacao.com/article/907324126-axe-compute-secures-260-million-three-year-enterprise-contract-for-2-304-gpu-nvidia-b300-deployment Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://healthreviewmacao.com/article/907324247-incannex-healthcare-psx-001-program-aligns-with-white-house-executive-order-accelerating-access-to-psychedelic-treatments-for-serious-mental-illness Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness https://ml.globenewswire.com/media/f484ac33-560c-412b-ba64-c65ac174d6f8/small/incannex-positive-png.png https://healthreviewmacao.com/article/907324260-tempest-announces-key-manufacturing-milestone-for-tpst-2003-dual-targeting-cd19-bcma-car-t Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://healthreviewmacao.com/article/907324293-immutep-announces-abstract-accepted-for-presentation-at-the-american-society-of-clinical-oncology-asco-2026-annual-meeting Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://healthreviewmacao.com/article/907326198-kestra-showcases-accelerated-innovation-at-hrs-2026 Health Review Macao en PressRelease 2026-04-22T12:00:00+00:00 Kestra Showcases Accelerated Innovation at HRS 2026 https://ml.globenewswire.com/media/93288f45-4a54-4de1-b66e-207047603f80/medium/kestra-medical-technologies-booth-at-hrs-2026.jpg https://healthreviewmacao.com/article/907322261-stereotaxis-announces-first-magic-procedures-in-the-united-states Health Review Macao en PressRelease 2026-04-22T11:58:00+00:00 Stereotaxis Announces First MAGiC Procedures in the United States https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://healthreviewmacao.com/article/907327183-glyco-harmony-drops-examined-2026-consumer-focused-report-on-ingredients-claims-label-insights Health Review Macao en PressRelease 2026-04-22T11:50:42+00:00 Glyco Harmony Drops Examined - 2026 Consumer-Focused Report on Ingredients, Claims & Label Insights https://ml.globenewswire.com/Resource/Download/39ec2fec-4677-48bb-9439-c393afc92116/image1.png https://healthreviewmacao.com/article/907323039-zevra-therapeutics-announces-details-for-q1-2026-financial-results-call Health Review Macao en PressRelease 2026-04-22T11:30:00+00:00 Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://healthreviewmacao.com/article/907323651-repligen-to-report-first-quarter-2026-financial-results Health Review Macao en PressRelease 2026-04-22T11:30:00+00:00 Repligen to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://healthreviewmacao.com/article/907324170-cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity Health Review Macao en PressRelease 2026-04-22T11:30:00+00:00 CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png https://healthreviewmacao.com/article/907324289-tg-therapeutics-announces-data-presentations-for-briumvi-in-multiple-sclerosis-at-the-american-academy-of-neurology-2026-annual-meeting Health Review Macao en PressRelease 2026-04-22T11:30:00+00:00 TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://healthreviewmacao.com/article/907325452-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Review Macao en PressRelease 2026-04-22T11:30:00+00:00 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png